Europe · Markets & Finance · Proactive Investors

AstraZeneca and Daiichi Sankyo team up with Summit on ivonescimab trials

Published by Proactive Investors · United Kingdom 12 h ago

AstraZeneca plc and Daiichi Sankyo, its Japanese partner, will test their cancer drug Datroway alongside ivonescimab from Summit Therapeutics, the US biotech, in breast, lung and…

Read the full article on Proactive Investors Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.proactiveinvestors.co.uk)

Also worth reading

City A.M.

Legal 500 takes down site after accidentally publishing damning barrister reviews

This is Money

SMALL CAP MOVERS: A calmer week for Aim as bond rout piles pressure on blue-chips

Financial Times

AstraZeneca and Daiichi Sankyo team up with Summit on ivonescimab trials

Share

Also worth reading

Legal 500 takes down site after accidentally publishing damning barrister reviews

SMALL CAP MOVERS: A calmer week for Aim as bond rout piles pressure on blue-chips

My mortgage is a problem for the Fed, and for America

Swiss Franc emerges as a safe-haven as global bonds sell off

Morning Bid: Yield to worst

Euro zone inflation surges, keeping pressure on ECB to hike